medRxivGenetic & Genomic MedicinePreprint
Multi-ancestry GWAS deciphers genetic architecture of abdominal aortic aneurysm and highlights PCSK9 as a therapeutic target
Tanmoy RoychowdhuryiD, Derek M. KlariniD, Michael G. LeviniD, Joshua Michael SpiniD, Yae Hyun RheeiD, Alicia C. Deng, Colwyn Ansel HeadleyiD, Ida L. SurakkaiD, Noah L. TsaoiD, Corry GellatlyiD, Verena ZuberiD, Fred Y. SheniD, Whitney HornsbyiD, Ina Holst LaurseniD, Shefali S. VermaiD, Adam E. LockeiD, Guðmundur EinarssoniD, Guðmar ÞorleifssoniD, Sarah E. GrahamiD, Ozan DikilitasiD, Jack W. PatteeiD, Renae JudyiD, Ferran Paüls-Vergés, Jonas Bille NielseniD, Brooke N. WolfordiD, , Scott M. DamraueriD
Abstract
Abdominal aortic aneurysm (AAA) is a common disease with significant heritability. In this study, we performed a genome-wide association meta-analysis from 14 discovery cohorts and uncovered 144 independent associations, including 97 previously unreported loci. A polygenic risk score derived from meta-analysis was able to explain AAA beyond clinical risk factors. Genes at AAA risk loci indicate involvement of lipid metabolism, vascular development and remodeling, extracellular matrix dysregulation and inflammation as key mechanisms in the pathogenesis of AAA. We further integrated functional data to elucidate expression of genes associated with AAA. These genes also indicate crossover between the development of AAA and other monogenic aortopathies, particularly via TGF-{beta} signaling pathways. Motivated by the strong evidence for the role of lipid levels in AAA by PheWAS, we identified therapeutic opportunities using Mendelian Randomization and, in pre-clinical studies, we demonstrated that PCSK9 inhibition in mice prevented the development of AAA.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 9
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of Novel Genetic Susceptibility Loci for Thoracic and Abdominal Aortic Aneurysms Via Genome-Wide Association Study Using the UK Biobank Cohort
Tamara Ashvetiya, Sherry X. Fan, … Charles C. Hong·PLoS ONEPeer-reviewed·Sep 1, 2021
- Could Metformin use reduce abdominal aortic aneurysm risk? A Mendelian randomisation study using known Metformin targets
Katie L. Saxby, Frank Dudbridge, … Christopher P. Nelson·medRxiv·Oct 13, 2023
- Polygenic Susceptibility of Aortic Aneurysms Associates to the Diameter of the Aneurysm Sac: the Aneurysm-Express Biobank Cohort.
Constance J.H.C.M. van Laarhoven, Jessica van Setten, … Sander W. van der Laan·Scientific ReportsPeer-reviewed·Dec 27, 2019
- Multi-trait GWAS of atherosclerosis detects novel pleiotropic loci
Tiffany R. Bellomo, William P. Bone, … Scott M. Damrauer·Frontiers in GeneticsPeer-reviewed·Feb 2, 2022
- Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibition attenuates abdominal aortic aneurysm formation via enhanced macrophage-dependent efferocytosis
Michael J. Fassler, Adithan Aravinthan, … Gilbert R. Upchurch·bioRxiv·Jun 26, 2026
- Evaluating the cost-effectiveness of polygenic risk score-stratified screening for abdominal aortic aneurysm
Martin Kelemen, John Danesh, … Lois G. Kim·Nature CommunicationsPeer-reviewed·Sep 14, 2024